CLEVELAND, March 29, 2017 -- Athersys, Inc. (NASDAQ:ATHX) announced today that Gil Van Bokkelen, Chairman and CEO, will present a corporate overview at the 16th Annual Needham Healthcare Conference at The Westin New York Grand Central Hotel in New York City. The presentation is scheduled for Tuesday, April 4, 2017 at 12:10 pm ET.
Investors interested in arranging a meeting with the Company's management during this conference should contact the conference coordinator.
A live webcast of the presentation can be accessed by visiting ‘Events & Presentations’ in the Investors Section on the Company's website at www.athersys.com. An archived replay of the webcast will be available for 90 days on the Company's website after the conference.
About Athersys
Athersys is an international biotechnology company engaged in the development of therapeutic products designed to extend and enhance the quality of human life. The Company is developing its MultiStem® cell therapy product, a patented, adult-derived "off-the-shelf" stem cell product, initially for disease indications in the neurological, cardiovascular, and inflammatory and immune disease areas, and has several ongoing clinical trials evaluating this potential regenerative medicine product. Athersys has forged strategic partnerships and a broad network of collaborations to further advance MultiStem cell therapy toward commercialization. More information is available at www.athersys.com. Follow Athersys on Twitter at www.twitter.com/athersys.
ATHX-G
Contact: William (B.J.) Lehmann, J.D. President and Chief Operating Officer Tel: (216) 431-9900 [email protected] David Schull Russo Partners, LLC Tel: (212) 845-4271 or (858) 717-2310 [email protected] Investor Contact: Peter Vozzo Westwicke Partners (443) 213-0505 or (443) 377-4767 (mobile) [email protected]


Zhipu AI Launches GLM-Image Model Trained on Huawei Chips, Boosting China’s AI Self-Reliance Drive
Rio Tinto–Glencore Talks Spark Pressure on BHP as Copper Fuels Mining Mega Deals
BlueScope Steel Announces A$1 Special Dividend After Asset Sales
Trump Weighs Blocking Exxon Investment as Venezuela Deemed “Uninvestable”
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration
NYC Nurses Strike Shuts Down 10 Private Hospitals as 15,000 Demand Safer Staffing and Benefits
Trump Administration Approves Nvidia H200 AI Chip Sales to China Under New Export Rules
Alphabet Stock Poised for Growth as Bank of America Sees Strong AI Momentum Into 2026
Amazon Reviews Supplier Costs as U.S.–China Tariffs Ease
Starlink Internet Remains Active in Iran Despite Nationwide Blackout
BlackRock to Cut Around 250 Jobs as CEO Larry Fink Pushes Strategic Shift
Saks Global Files for Bankruptcy Protection Amid Mounting Luxury Retail Pressures
Trump Considers Starlink to Restore Internet Access in Iran Amid Protests
Taiwan Issues Arrest Warrant for OnePlus CEO Over Alleged Illegal Recruitment Activities
Tesla, EEOC Move Toward Mediation in Racial Harassment Lawsuit
SK Hynix to Invest $13 Billion in Advanced Chip Packaging Plant as AI Memory Demand Surges
Allegiant to Acquire Sun Country Airlines in $1.5 Billion Deal to Expand U.S. Leisure Travel Network 



